These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 10495037

  • 21. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
    Seeman P, Ko F, Willeit M, McCormick P, Ginovart N.
    Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
    Piggott MA, Marshall EF, Thomas N, Lloyd S, Court JA, Jaros E, Burn D, Johnson M, Perry RH, McKeith IG, Ballard C, Perry EK.
    Brain; 1999 Aug; 122 ( Pt 8)():1449-68. PubMed ID: 10430831
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Dopaminergic receptors on lymphocytes in idiopathic Parkinson's disease (author's transl)].
    Le Fur G, Meininger V, Baulac M, Phan T, Uzan A.
    Rev Neurol (Paris); 1981 Aug; 137(2):89-96. PubMed ID: 7244495
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Expression of dopamine receptors in immune organs and circulating immune cells.
    Ricci A, Mariotta S, Greco S, Bisetti A.
    Clin Exp Hypertens; 1997 Aug; 19(1-2):59-71. PubMed ID: 9028635
    [Abstract] [Full Text] [Related]

  • 30. The peripheral dopaminergic system: morphological analysis, functional and clinical applications.
    Amenta F, Ricci A, Tayebati SK, Zaccheo D.
    Ital J Anat Embryol; 2002 Aug; 107(3):145-67. PubMed ID: 12437142
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease.
    Kaasinen V, Någren K, Hietala J, Oikonen V, Vilkman H, Farde L, Halldin C, Rinne JO.
    Neurology; 2000 Apr 11; 54(7):1482-7. PubMed ID: 10751262
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
    Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW.
    Neuropsychopharmacology; 1987 Dec 11; 1(1):5-15. PubMed ID: 2908095
    [Abstract] [Full Text] [Related]

  • 39. Plausible improvements for selective targeting of dopamine receptors in therapy of Parkinson's disease.
    Luthra PM, Kumar JB.
    Mini Rev Med Chem; 2012 Dec 11; 12(14):1556-64. PubMed ID: 22697513
    [Abstract] [Full Text] [Related]

  • 40. Dopaminergic agonists in the treatment of Parkinson's disease: a review.
    Piccoli F, Riuggeri RM.
    J Neural Transm Suppl; 1995 Dec 11; 45():187-95. PubMed ID: 8748625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.